Market Tracker

09/04 6:01pm ET

Depomed Inc (NASDAQ:DEPO)

26.66
Delayed Data
As of Sep 04
 +0.04 / +0.15%
Today’s Change
13.47
Today|||52-Week Range
33.74
+65.49%
Year-to-Date

Today’s Trading

Previous close26.62
Today’s open26.24
Day’s range26.01 - 26.85
Volume688,226
Average volume (3 months)1,879,258
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)+135.58%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+190.87%
P/E ratio26.0
Price/Sales2.74
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
DNAIProNAi Therapeutics ...-1.02-3.26%
VBLTVascular Biogenics L...-0.09-1.59%
NEPTNeptune Technologies...-0.01-1.04%
TEVATeva Pharmaceutical-0.68-1.06%
Data as of 4:00pm ET, 09/04/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.20
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts